Lv1
40 积分 2022-04-24 加入
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
6天前
已完结
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
10天前
已完结
CD3 bispecific antibody–induced cytokine release is dispensable for cytotoxic T cell activity
13天前
已完结
Tuning T cell receptor sensitivity through catch bond engineering
1个月前
已完结
Beta-2 Microglobulin Knockout K562 Cell-Based Artificial Antigen Presenting Cells For Ex Vivo Expansion of T Lymphocytes
2个月前
已完结
A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy
3个月前
已完结
De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells
4个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
4个月前
已完结
Optimization of a novel 2+2 BCMA x CD3 bispecific antibody for minimized cytokine release and potent efficacy
8个月前
已完结
皖公网安备34019202002308
